Hypersensitivity Mechanisms Flashcards
Type II Hypersensitivity Immune Reactant
IgG
Type 1 Hypersensitivity Immune reactant
IgE
Type III Hypersensitivity Immune Reactant
IgG
Type IV Hypersensitivity Immune Reactants
Th1, Th2, CTL
Type I Hypersensitivity Reaction
immediate response
Type IV Hypersensitivity
Later response
Type I Hypersensitivity Antigens
soluble antigens
Type II Hypersensitivity Antigens
~Cell or matrix associated antigen
~Cell-surface antigen
Type III Hypersensitivity Antigens
Soluble Ags
Type IV Hypersensitivity Antigens (& associated Immune Reactants)
Th1 = soluble Ag Th2 = soluble Ag CTL = cell-associated Ag
Type I Hypersensitivity Effector Mechanism
Mast-cell activation
Type II Hypersensitivity Effector Mechanism for cell- or matrix-associated Ags
Complement, FcR+ cells (phagocytes, NK cells)
Type II Hypersensitivity Effector Mechanism for cell-surface receptors
Ab alter signaling
Type III Hypersensitivity Effector Mechanism
Complement & phagocytes
Type IV Hypersensitivity Effector Mechanism for Th1
Macrophage activation
Type IV Hypersensitivity Effector Mechanism for Th2
IgE production, eosinophil activation, mastocytosis
Type IV Hypersensitivity Effector Mechanism for CTL
Cytotoxicity
Type I Hypersensitivity Reaction Examples
allergic rhinitis, atopic eczema,
Type II Hypersensitivity Reaction Examples
~Some drug allergies (penicillin)
~chronic urticaria (Ab against FceRI alpha chain)
Type III Hypersensitivity Reaction Examples
serum sickness, Arthus reaction
Type IV Hypersensitivity Reaction Examples
Th1 = Allergic contact dermatitis, tuberculin reaction Th2 = Chronic asthma, CTL = graft rejection, poison ivy reaction
Hypersensitivity Types represent..
altered sensitivity or a sensitivity to harmless or innocuous Ags
Hypersensitivity reactions result from…
adaptive immune response
When do hypersensitivity reactions occur?
AFTER animal is 1st ‘sensitized’ to offending Ag.
Type I Antigens are also called…
allergens
Allergen delivery
~ @ low doses across mucosal surfaces
~ percutaneously (insect bite)
Type I Sensitization
~occurs in mucosal tissues where IgE is made
~IgE sensitizes mast cells & basophils by binding to their Fce-receptor
Type I Damage Mechanisms
~mast cell activation causes damage because it releases histamine, prostaglandins, & leukotrienes
~no new IgE synthesis needed
Type I Hypersensitivity Characteristics
- rapid onset
- microvascular response
- mucosal responses: ^ mucus secretion & sm. m. contraction
- no leukocytes accumulation
Late-Phase Reaction (LPR)
~delayed onset (3+ hours) in SOME people/animals
Late-Phase Reaction (LPR) mechanism
mast cell cytokines recruit leukocytes to region
Significance of Late-Phase Response (LPR)
- Antihistamines are ineffective against LPR
2. Presence of LPR is associated with more severe reactions
Chronic Type I Hypersensitivity Reaction Examples
~Canine Atopic Dermatitis
~Anaphylaxix
~Equine Recurrent Airway Obstruction (RAO)
Chronic Type I Hypersensitivity Reaction Mechanisms
Th1, Th2, Tgamma-delta, eosinophils, & macrophages infiltrate inflamed tissues (TYPE I + TYPE IV)
Anaphylaxis
~systemic form of Type I Hypersensitivity
~Mild = generalized edema
~Severe = systemic hypotension & collapse
~respiratory tract affected (lung edema)
Canine Atopic Dermatitis
~allergens inhaled, ingested, &/or absorbed percutaneously
~lesions location = paws, axillary, inguinal area & face
~can coexist with Type IV
Equine Recurrent Airway Obstruction (RAO)
AKA…
Chronic Obstructive Pulmonary Disease (COPD)
Equine Recurrent Airway Obstruction (RAO) affects
alveolar walls.
Equine Recurrent Airway Obstruction (RAO) Ags
mold spores from dust or molds in stalls/barns
How do you ID offending Ags in Type 1?
~Intradermal Skin Testing
~Serologic test based on ELISA for IgE only
Intradermal Skin Testing
~intradermal injection of potential allergens => Mast cell activation via IgE:Ag binding => QUICK inflammatory reaction of swelling/redness
Immunotherapy for Type I Hypersensitivity
Allergen-Specific Immunotherapy (ASIT) = hyposensitization = desensitization
Allergen-Specific Immunotherapy (ASIT) Mechanism
administering increasing doses of allergen over time